Class Action Defense
Representative experience
- Defense of Merck & Co. in three class actions concerning the pain relief drug Vioxx.
- Defense of GlaxoSmithKline in class action litigation concerning the drug Avandia (indicated for diabetes type 2).
- Defense of Eli Lilly & Co. in a class action litigation concerning the drug Zyprexa (indicated for schizophrenia and bipolar disorder).
- Defense of Solbar Hatzor. in an NIS 112 million class action claim.
- Defense of a large Israeli investment bank in a class action claim in the amount of NIS 60 million.
- Defense of an accounting firm in an NIS 25 million class action for professional negligence.
- Defense of a publicly traded company in a NIS 170 million class action alleging misrepresentation to investors.
- Defense of a publicly traded company in a multi-million dollar class action alleging a violation of mandatory tender offer rules.
- Defense of the Tel Aviv and Eilat municipalities in class actions alleging illegal collection of water and sewage fees.
- Defense of the Israeli Yellow Pages in a class action claim regarding its business practices.
Practice area's Partners:
Leshem, Israel (Reli)
Weisman, Nadav
Rosovsky, Eyal
Antonelli, Yael
Arbel, Neta
Avrahami, Hagit
Bar, Royi
Bar-Shalom, Liran
Ben Artzi Halpern, Merav
Birger, Issar
Bursztyn, Ali
Dalach, Roy
Dolev, Amir
Ettinger, Yossi
Fremder, Adi
Frishtik, Gidi
Gellert, Alon
Gilad, Rotem
Goldstein, David
Kedem, Dror
Koppel-Aviv, Adi
Landa, Rami
Laron, Edan
Levi, Doron
Lipsky-Taichman, Bat-hen
Magen, Alon
Niemoj, Asaf
Oestreicher, Yoav
Paz, Daniel
Peleg, Ron
Rakover, Ariel
Ramot, Sivan
Reichart, Lior
Roginkin, Boris
Sasson, Yuval Z.
Schiff, Gilad
Shalev, Yafit
Shapira, Adam
Tesler, Michael
Yoeli, Alon
Ziv, Ronen